1[1]Mccully KS.Vascular pathology of homocysteinemia:Implication for the pathgenesis of atherosclerosis[J].AW Pathol,1969,56(3):111-128.
2[2]Perry IJ,Refsum H,Moms R,et al.Prospective and risk of storke in middle-age Britishmen[J].Lancet,1995,346(25):1395-1399.
3[3]Huang HW,Guo MH,Lin RJ,et al.Hyperhomocysteinemia is a risk factor of middle cerebral artery stenosis[J].J Neurol,2007,254(3):364-367.
4[4]Yang F,Tan HM,Wang H.Hyperhomocysteinemia and atherosclerosis[J].Sheng Li Xue Bao,2005,57(2):103-114.
5[5]Sen U,Tyagi N,Moshal KS,et al.Cardiac synchronous and dys-synchronous remodeling in diabetes mellitus[J].Antioxid Redox Signal,2007,9(7):971-978.
6[6]Sahin M,Tutuncu NB,Ertugrul D,et al.Effects of metformin or rosiglitazone on serum concentrations of homocysteine,folate,and vitamin B12 in patients with type 2 diabetes mellitus[J].J Diabetes Complications,2007,21(2):118-123.
7[7]Okada E,Oida K,Tada H,et al.Hyperhomocysteinemia is a risk factor for comonary arteriosclerosis in Japanese patients with type 2 diabetes[J].Diabetes Care,1999,22:484-490.
8Austin RC, Lentz SR,Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease [J]. Cell Death Differ, 2004,11 (suppl 1) : 56-64.
9Van der Griend R,Biesma DH, Banga JD. Hyperhomocysteinaemia as a cardiovascular risk factor: an update[J]. Neth J Meal,2000,56(3) :119-130.
10Bermudez M, Frank N, Bernal J,et al. High prevalence of CBS T191M mutation in homocystinurie patients from Colombia[J]. Hum Murat,2006,27(3) : 296-299.
